You are currently viewing a new version of our website. To view the old version click .

Molecular Mechanisms and New Targets of Refractory Asthma

This special issue belongs to the section “Biochemistry and Molecular Biology“.

Special Issue Information

Dear Colleagues,

Asthma is a chronic obstructive inflammatory airway disease with substantial morbidity and mortality, affecting over 300 million people worldwide. Airway hyperresponsiveness and airway inflammation are hallmarks of asthma clinically managed with β2-agonist bronchodilators and corticosteroids. Refractory asthma manifests with persistent symptoms despite the use of high-dose corticosteroids and long-acting β2-agonists, leading to increased morbidity and costs associated with treatment. Understanding the mechanisms and developing strategies to overcome this therapeutic resistance pose a significant unmet need.

For this Special Issue, “Molecular Mechanisms and New Targets of Refractory Asthma”, we welcome the submission of original articles and reviews that explore all biological aspects of refractory asthma, with an emphasis on molecular mechanisms and new therapeutic targets. The goal of this Special Issue is to improve our understanding of the therapeutic resistance in asthma, and provide valuable insights to address the overarching challenge of refractory asthma.

Prof. Dr. Yaping Tu
Prof. Dr. Steven S. An
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biology is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • refractory asthma
  • airway hyperresponsiveness
  • T2 and non-T2 inflammation
  • steroid resistance
  • therapeutic targets

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Published Papers

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Biology - ISSN 2079-7737